Research
Neural
Chronic co-administration of OXT and GLP-1 decreases body weight without changing food intake.
Combining OXT with GLP-1 may be an effective strategy for reducing body weight in obese populations.
StrongSupportsmedium confidence
The chronic OXT/GLP-1 co-administration decreased BW without changing FI.
Why this rating
Based on the study design involving chronic treatment and measurement of outcomes.
Source
Systemic Co-Administration of Low-Dose Oxytocin and Glucagon-Like Peptide 1 Additively Decreases Food Intake and Body Weight
Yuko Maejima et al. · Neuroendocrinology · 2024
DOI 10.1159/000538792
otherCited 8×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Neural
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →